Genetic polymorphisms of CYP2E1 and GSTM1 in a Thai population

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 3, 2006, Pages 415-419

  Sangrajrang, Suleeporn ^a   Jedpiyawongse, Adisorn ^a   Srivatanakul, Petcharin ^a  

^a NATIONAL CANCER INSTITUTE   (Thailand)

Author keywords

CYP2E1; Genetic polymorphisms; GSTM1

Indexed keywords

CYTOCHROME P450 2E1; ENDODEOXYRIBONUCLEASE AHAIII; ENDODEOXYRIBONUCLEASE PSTI; ENDODEOXYRIBONUCLEASE RSAI; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ADULT; AGED; ALLELE; ARTICLE; ASIAN; CAUCASIAN; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; METABOLISM; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THAILAND;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CYTOCHROME P-450 CYP2E1; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; THAILAND;

EID: 39049185305     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Anwar WA, Abdel-Rahman SZ, El-Zein RA, Mostafa HM, Au WW, (1996). Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis, 9, 1923-9.
2. Beeghly A, Katsaros D, Chen H, et al. (2006). Glutathione Stransferase polymorphisms and ovarian cancer treatment and survival. Gynecol Oncol, 100, 330-7.
3. Bell DA, Taylor JA, Paulson DF, et al. (1993). Genetic risk and carcinogen metabolism gene glutathione transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst, 85, 1159-64.
4. Brockmoller J, Kerb R, Drakoulis N, Nitz M, Roots I, (1993). Genotype and phenotype of glutathione S-transferase class mu isoenzyme mu and psi in lung cancer patients and controls. Cancer Res, 53, 1004-11.
5. Cho HJ, Lee SY, Ki CS, Kim JW, (2005). GSTM1, GSTT1 and GSTP1 polymorphisms in the Korean population. J Korean Med Sci, 20, 1089-92.
6. D'Errico A, Malats N, Vineis P, Boffetta P (1999). Review of studies of selected metabolic polymorphisms and cancer. In: Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, Boffetta P editors, Metabolic polymorphisms and susceptibility to cancer. No. 148, IARC Scientific Publication. pp. 323-394.
7. Deakin M, Elder J, Hendrickse C, et al. (1996). Glutathione Stransferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis (Lond.), 17, 881-884.
8. Doll R, Peto R. (1981) Causes of Cancer. Oxford University Press, New York.
9. Guengerich FP (1990) Characterization of the roles of human cytochrome P450 enzymes in carcinogen metabolism. Asia Pac J Pharmacol, 5, 327-45.
10. Guengerich FP (1989). Polymorphism of cytochrome P-450 in humans. Trends Pharmacol Sci, 10, 107-9.
11. Hayashi SI, Watanabe J, Kakajiri K (1991). Genetic polymorphisms in the 5'-Flanking region change transcriptional regulation of the human cytochrome p450IIEI gene. J Biochem, 110, 559-65.
12. Hayes JD, Pulford DJ (1995). The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol, 30, 445-600.
13. Hildesheim A, Anderson LM, Chen CJ, et al. (1997). CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst, 89, 1207-12.
14. Hirvonen A, Husgafvel-Pursainen K, Anttila S, Karjalainen A, Vanio H, (1993). The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphism in a Finish study population. Carcinogenesis, 14, 85-88.
15. Hsieh L, Huang R, Yu M, Chen C, Liaw Y (1996). L-myc GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers. Cancer Lett, 103, 171-6.
16. Idle J (1991). Is environmental carcinogenesis modulated by host polymorphism? Mut Res, 247, 259-66.
17. Kelsey KT, Spitz MR, Zuo ZF, Wiencke JK, (1997). Polymorphisms in the glutathione S-transferase class m and q genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States). Cancer Causes Control, 8, 554-559.
18. Kietthubthew S, Sriplung H, Au WW, (2001). Genetic and Environmental interactions on oral sancer in southern Thailand. Environ Mol Mutagenesis, 37, 111-6.
19. Kihara M, Noda K, Kihara M, (1995). Distribution of GSTM1 null genotype in relation to gender, age and smoking status in Japanese lung cancer patients. Pharmacogenetics, 5, S74-9.
20. Kongruttanachok N, Sukdikul S, Setavarin S, et al. (2001). Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer, 1, 4.
21. Le Marchand L, Sivaraman L, Pierce L, et al. (1998). Association of CYP1A1, GSTM1 and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res, 58, 4858-63.
22. London SJ, Daly AK, Cooper J, et al. (1995). Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst, 87, 1246-53.
23. Lucas D, Menez C, Floch F, et al. (1996). Cytochromes P4502E1 and P4501E1 genotypes and susceptibility to cirrhosis or upper aerodigestive tract cancer in alcoholic Caucasians. Alcoholism: Clin Exp Res, 20, 1033-1037.
24. Maezawa Y, Yamauchi M, Toda G (1994). Association between restriction fragment length polymorphism of the human cytochrome p450IIEI gene and susceptibility to alcoholic liver cirrhosis. Am J Gastroenterol, 89, 561-5.
25. Mannervik B, Awasthi YC, Board PG, et al. (1992). Nomenclature for human glutathione transferases. Biochem J, 282, 305-306.
26. Mishra DK, Kumer A, Srivastava DS, Mittal RD, (2004). Allelic variation of GSTT1, GSTM1 and GSTP1 gene in North Indian population. Asian Pac J Cancer Prev, 5, 362-5.
27. Mittal RD, Srivastava DSL, Mandhani A, Mittal B, (2005). Genetic polymorphism of Drug metabolizing enzymes (CYP2E1, GSTP1) and susceptibility to bladder cancer in north India. Asian Pacific J Cancer Prev, 6, 6-9.
28. Oyama T, Kawamoto T, Mizuoe T, et al. (1997). Cytochrome P450 2E1 polymorphism as a risk factor for lung cancer in relation to p53 gene mutation. Anticancer Res, 17, 583-588.
29. Persson I, Jonansson I, Bergling H, et al. (1993). Genetic polymorphism of cytochrome p4502E1 in Swedish population. FEBS, 319, 207-211.
30. Roots L, Drakoulis N, Brokmoller J (1992). Polymorphic enzymes and cancer risk: concepts, methodology and data review. In: Kalow R editors, Pharmacogenetics of Drug Metaboilsm. Pergamon Press, pp. 815-841.
31. Ryberg D, Skaug V, Hewer A, et al. (1997). Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis, 18, 1285-9.
32. Sikdar N, Mahmud SA, Paul RR, Roy B, (2003). Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett, 193, 33-42.
33. Strange RC, Fryer AA, (1999). The glutathione S-transferase: influence of polymorphism on cancer susceptibility. In: Vineis P editors Metabolic polymorphism and susceptibility to cancer. IARC Scientific Publication, Lyon France, pp. 231-49.
34. Tan W, Song N, Wang GW, et al. (2000). Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione Stransferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev, 9, 551-6.
35. Tiwawech D, Srivatanakul P, Karalak A, Ishida T, (2005). Glutathione S-transferase M1 gene polymorphism in Thai nasopharyngeal carcinoma. Asian Pacific J Cancer Prev, 6, 270-5.
36. To-Figueras J, Gene M, Gomez-Catalan J, et al. (1997). Glutathione S-transferase M1 (GSTM1), and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans. Carcinogenesis, 18, 1529-1533.
37. Uematsu F, Ikawa S, Kikuchi H, et al. (1994). Restriction fragment length polymorphism of the human CYP2E1 (cytochrome P450IIE1) gene and susceptibility to lung cancer: possible relevance to low smoking exposure. Pharmacogenetics, 4, 58-63.
38. Uematsu F, Kikuchi H, Motomiya M, et al. (1991). Association between restriction fragment length polymorphism of human cytochrome P4502E1 gene and susceptibility to lung cancer. Jpn J Cancer Res, 82, 254-6.
39. Wang SL, Lee H, Chen KW, et al. (1999). Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. Lung Cancer, 26, 27-34.
40. Wong NACS, Rae F, Simpson KJ, Murray GD, Harrison DJ (2000). Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: a study and literature review, includingg meta-analysis. J Clin Pathol Mol Pathol, 53, 88-93.
41. Wong RH, Du CL, Wang JD, et al. (2002). XRCC1 and CYP2E1 polymorphisms as susceptibility factors of plasma mutant p53 protein and anti-p53 antibody expression in vinyl chloride monomer-exposed polyvinyl chloride workers. Cancer Epidemiol Biomarkers Prev, 11, 475-82.
42. Zhao B, Seow A, Lee EJD, et al. (2001). Dietary isothiocyanated, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev, 10, 1063-7.
43. Zhong SL, Zhou S, Chen X, Huang M. (2006). Rapid determinatioon of common mutations in glutathione S-transferase gene by PCR-based methods in healthy Chinese. Clin Chim Acta, 364, 205-8.